Article
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma - Nature Reviews Urology
Rating:
0.0
Views:
78
Likes:
1
Library:
1
The therapeutic algorithm of renal cell carcinoma has been revolutionized by the approval of immunotherapy agents by regulatory agencies. However, objective and durable responses are still not observed in a large number of patients, and prognostic and predictive biomarkers for immunotherapy response are urgently needed.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value